A Paradox of Transcriptional and Functional Innate Interferon Responses of Human Intestinal Enteroids to Enteric Virus Infection
Overview
Authors
Affiliations
The intestinal epithelium can limit enteric pathogens by producing antiviral cytokines, such as IFNs. Type I IFN (IFN-α/β) and type III IFN (IFN-λ) function at the epithelial level, and their respective efficacies depend on the specific pathogen and site of infection. However, the roles of type I and type III IFN in restricting human enteric viruses are poorly characterized as a result of the difficulties in cultivating these viruses in vitro and directly obtaining control and infected small intestinal human tissue. We infected nontransformed human intestinal enteroid cultures from multiple individuals with human rotavirus (HRV) and assessed the host epithelial response by using RNA-sequencing and functional assays. The dominant transcriptional pathway induced by HRV infection is a type III IFN-regulated response. Early after HRV infection, low levels of type III IFN protein activate IFN-stimulated genes. However, this endogenous response does not restrict HRV replication because replication-competent HRV antagonizes the type III IFN response at pre- and posttranscriptional levels. In contrast, exogenous IFN treatment restricts HRV replication, with type I IFN being more potent than type III IFN, suggesting that extraepithelial sources of type I IFN may be the critical IFN for limiting enteric virus replication in the human intestine.
Loss of mucin 2 and MHC II molecules causes rare resistance to murine RV infection.
Bomidi C, Sawyer F, Sawyer F, Shroyer N, Conner M, Estes M J Virol. 2024; 99(2):e0150724.
PMID: 39727412 PMC: 11852729. DOI: 10.1128/jvi.01507-24.
In Vitro Culture of Human Norovirus in the Last 20 Years.
Cheng C, Cai X, Li J, Zhang X, Xie Y, Zhang J Biomedicines. 2024; 12(11).
PMID: 39595008 PMC: 11592199. DOI: 10.3390/biomedicines12112442.
Pathoimmunological analyses of fatal E11 infection in premature infants.
Luo W, Wang L, Chen Z, Liu M, Zhao Y, Wu Y Front Cell Infect Microbiol. 2024; 14:1391824.
PMID: 39045132 PMC: 11263194. DOI: 10.3389/fcimb.2024.1391824.
The application of organoids in colorectal diseases.
Liu Y, Wang D, Luan Y, Tao B, Li Q, Feng Q Front Pharmacol. 2024; 15:1412489.
PMID: 38983913 PMC: 11231380. DOI: 10.3389/fphar.2024.1412489.
Kalugotla G, Marmerstein V, Baldridge M Curr Opin Immunol. 2024; 87:102425.
PMID: 38763032 PMC: 11162908. DOI: 10.1016/j.coi.2024.102425.